Navigation Links
Omnicell Announces First Quarter 2008 Results
Date:4/21/2008

rmance, the measures give us a better understanding of how we should invest in research and development, fund infrastructure growth and evaluate marketing strategies. In calculating the above non-GAAP results, management specifically adjusted for the following excluded items:

a) Stock-based compensation expense impact of SFAS No. 123R. We recognize

equity plan-related compensation expenses, which represent the fair

value of all share-based payments to employees, including grants of

employee stock options, as required under SFAS No. 123 (revised 2004),

"Share-Based Payment" (SFAS No. 123R).

b) Income tax benefit from tax valuation allowance release. This refers to

the recognition of an income tax benefit from the partial reversal of

our tax valuation allowance on specific deferred tax assets that is no

longer required. Under Statement of Financial Accounting Standards No.

109, the release of the tax valuation allowance is necessary, primarily

as a result of achieving sustained profitability in certain tax

jurisdictions.

Management adjusts for the excluded items because management believes that, in general, these items possess one or more of the following characteristics: their magnitude and timing is largely outside of Omnicell's control; they are unrelated to the ongoing operation of the business in the ordinary course; they are unusual and we do not expect them to occur in the ordinary course of business; or they are non-operational, or non-cash expenses involving stock option grants.

We believe that the presentation of these non-GAAP financial measures is warranted for several reasons:

1) Such non-GAAP financial measures provide an additional analytical tool

for understanding Omnicell's financial performance by excluding the

impact of items which may obscure trends in the core operating results

of the
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Omnicell Schedules First Quarter 2008 Earnings Call
2. Omnicell Announces Completion of Its Common Stock Repurchase Plan
3. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
4. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
5. Omnicell Schedules Fourth Quarter Earnings Call
6. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
7. Omnicell Announces Agreement to Acquire Rioux Vision, Inc.
8. Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
9. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
10. Omnicell Reports Strong Q3 Revenue and Profit Growth
11. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
Post Your Comments:
*Name:
*Comment:
*Email: